Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes
2007

Insulin Treatment Appraisal Scale for Type 2 Diabetes

Sample size: 282 publication Evidence: high

Author Information

Author(s): Snoek Frank J, Skovlund Søren E, Pouwer Frans

Primary Institution: VU University Medical Center Amsterdam

Hypothesis

The insulin treatment appraisal scale (ITAS) was developed to assess patients' perceptions of insulin therapy in type 2 diabetes.

Conclusion

The ITAS is a reliable and valid tool for assessing both positive and negative perceptions of insulin treatment in patients with type 2 diabetes.

Supporting Evidence

  • The ITAS showed high internal consistency with a Cronbach's alpha of 0.89.
  • Patients using insulin had significantly less negative appraisals than insulin naive patients.
  • The study confirmed concurrent validity with significant correlations between ITAS scores and other measures of emotional distress.

Takeaway

This study created a questionnaire to help understand how people with diabetes feel about insulin treatment, showing that those on insulin tend to have a better view of it than those who are not.

Methodology

282 patients with type 2 diabetes completed the ITAS and other psychological measures; reliability and validity were tested using exploratory factor analysis and correlation coefficients.

Potential Biases

The sample may not be representative due to the low response rate and limited diversity.

Limitations

The study had a low response rate of 29% and included a limited ethnic background, which may bias the results.

Participant Demographics

Mean age was 59 years, 54% were female, and the average duration of diabetes was 5.1 years.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1477-7525-5-69

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication